Coexpression cluster:C1037

Full id: C1037_acute_medulloblastoma_Monocytederived_CD4_diffuse_testicular_small

Phase1 CAGE Peaks

Hg19::chr14:73566082..73566112,+	p@chr14:73566082..73566112 +
Hg19::chr14:73570051..73570166,+	p@chr14:73570051..73570166 +
Hg19::chr14:73572641..73572756,+	p4@RBM25
Hg19::chr1:109241850..109241862,+	p6@PRPF38B
Hg19::chr1:109241964..109241981,+	p2@PRPF38B
Hg19::chr1:109241994..109242012,+	p4@PRPF38B
Hg19::chr1:109242036..109242049,+	p5@PRPF38B
Hg19::chr1:70710380..70710454,+	p@chr1:70710380..70710454 +

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

p.value	FDR	nGenes	nPathway	Name
1.99497924496294e-05	0.0126282186206154	2	128	Spliceosome (KEGG):03040

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0008380	RNA splicing	0.00102948989227113
GO:0006397	mRNA processing	0.00102948989227113
GO:0016071	mRNA metabolic process	0.00107790320168466
GO:0006396	RNA processing	0.0019070019214864
GO:0003729	mRNA binding	0.0128043276729378
GO:0000375	RNA splicing, via transesterification reactions	0.0164674225721434
GO:0000398	nuclear mRNA splicing, via spliceosome	0.0164674225721434
GO:0000377	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	0.0164674225721434
GO:0005681	spliceosome	0.0290367588376599
GO:0016070	RNA metabolic process	0.0478583864116401

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n
hematopoietic oligopotent progenitor cell	5.48e-10	161
hematopoietic multipotent progenitor cell	5.48e-10	161
hematopoietic stem cell	2.41e-09	168
angioblastic mesenchymal cell	2.41e-09	168
nongranular leukocyte	1.49e-08	115
hematopoietic cell	4.93e-08	177
classical monocyte	6.07e-07	42
CD14-positive, CD16-negative classical monocyte	6.07e-07	42
hematopoietic lineage restricted progenitor cell	7.88e-07	120

Uber Anatomy

Ontology term	p-value	n
neural tube	2.96e-08	56
neural rod	2.96e-08	56
future spinal cord	2.96e-08	56
neural keel	2.96e-08	56
regional part of nervous system	2.20e-07	53
regional part of brain	2.20e-07	53
regional part of forebrain	3.80e-07	41
forebrain	3.80e-07	41
anterior neural tube	3.80e-07	41
future forebrain	3.80e-07	41
nervous system	9.05e-07	89
brain grey matter	9.51e-07	34
gray matter	9.51e-07	34

Disease

Ontology term	p-value	n
cancer	1.22e-23	235
disease of cellular proliferation	6.57e-23	239
organ system cancer	2.34e-11	137
cell type cancer	2.45e-11	143
hematologic cancer	3.37e-11	51
immune system cancer	3.37e-11	51
leukemia	1.32e-09	39
carcinoma	4.62e-08	106
myeloid leukemia	9.47e-07	31

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

This analysis result is provided for C0 - C305 clusters.